DSWL [DESWELL INDUSTRIES] 6-K: Annual meeting at 10 a.m. local time on
[Annual meeting at 10 a.m. local time on Wednesday, September 10, 2014 th]
JST [JINPAN INTERNATIONAL] 6-K: JINPAN INTERNATIONAL LIMITED
[JINPAN INTERNATIONAL LIMITED]
CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)
[China Yuchai International Announces Unaudited Second Quarter 2014 Financial Results SINGAPORE, Singapore August 11, 2014 China Yuchai International Limited Financial highlights for the second quarter of 2014 Revenue was RMB 4.2 billion (US$684.6 million) which was similar to the second quarter of 2013; Gross profit was RMB 816.8 million (US$132.8 million), a 19.4% gross margin compared with] [CHINA YUCHAI INTERNATIONAL LIMITED UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS For the quarters ended June 30, 2014 and 2013 (RMB and US$ amounts expressed in thousands, except per share data) June 30, 2014 June 30, 2013 RMB 000 US$ 000 RMB 000 US$ 000 Revenue 4,212,298 684,615 4,207,482 683,832 Cost of goods sold (3,395,460 ) (551,856 ) (3,396,703 )] [TABLE OF CONTENTS 99.1 Press release dated August 11, 2014 China Yuchai International Announces Unaudited Second Quarter 2014 Financial Results 99.2 Unaudited Financial Statements for the Second Quarter 2014 and Six Months Ended June 30, 2014 CHINA YUCHAI INTERNATIONAL LIMITED Weng Ming Hoh President and Director 6-K 1 d769814d6k.htm FORM 6-K]
JST [JINPAN INTERNATIONAL] 6-K: (Original Filing)
[JINPAN INTERNATIONAL LIMITED]
CYD [CHINA YUCHAI INTERNATIONAL] 6-K: China Yuchai International Announces Unaudited Second Quarter 2014
[China Yuchai International Announces Unaudited Second Quarter 2014 Financial Results SINGAPORE, Singapore August 11, 2014 China Yuchai International Limited Financial highlights for the second quarter of 2014 Revenue was RMB 4.2 billion (US$684.6 million) which was similar to the second quarter of 2013; Gross profit was RMB 816.8 million (US$132.8 million), a 19.4% gross margin compared with] [CHINA YUCHAI INTERNATIONAL LIMITED UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS For the quarters ended June 30, 2014 and 2013 (RMB and US$ amounts expressed in thousands, except per share data) June 30, 2014 June 30, 2013 RMB 000 US$ 000 RMB 000 US$ 000 Revenue 4,212,298 684,615 4,207,482 683,832 Cost of goods sold (3,395,460 ) (551,856 ) (3,396,703 )] [TABLE OF CONTENTS 99.1 Press release dated August 11, 2014 China Yuchai International Announces Unaudited Second Quarter 2014 Financial Results 99.2 Unaudited Financial Statements for the Second Quarter 2014 and Six Months Ended June 30, 2014 CHINA YUCHAI INTERNATIONAL LIMITED Weng Ming Hoh President and Director 6-K 1 d769814d6k.htm FORM 6-K]
JST [JINPAN INTERNATIONAL] 6-K: JINPAN INTERNATIONAL LIMITED
[JINPAN INTERNATIONAL LIMITED]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Second Quarter 2014 Financial Results Shenzhen, China – August 11, 2014 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014. Highlights for Second Quarter 2014 - Net revenues increased 8.9% year-over-year to $334.5 million. International] []
VNET [21Vianet] 6-K: (Original Filing)
[21Vianet Group, Inc. to Acquire Dermot Entities from DYXnet Group BEIJING, Aug. 11, 2014 (GLOBE NEWSWIRE) 21Vianet Group, Inc. (Nasdaq:VNET) (21Vianet or the Company), the largest carrier-neutral Internet data center services provider in China, today announced that the Company and its affiliate have entered into definitive agreements to acquire from DYXnet Group the entire equity interest in Dermot Holdings] [FORM 6-K 21Vianet Group, Inc. M5, 1 Jiuxianqiao East Road, Chaoyang District Beijing 100016 The Peoples Republic of China (86 10) 8456 2121 x ¨ Form 20-F 21Vianet Group, Inc. Shang-Wen Hsiao Chief Financial Officer 6-K 1 d774339d6k.htm FORM 6-K]
MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2014 Financial Results Shenzhen,
[Mindray Announces Second Quarter 2014 Financial Results Shenzhen, China – August 11, 2014 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014. Highlights for Second Quarter 2014 - Net revenues increased 8.9% year-over-year to $334.5 million. International] []
